It's not just broker upgrades sending the CSL share price higher

The CSL Limited (ASX: CSL) share price has been on a tear in June.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

a woman

The CSL Limited (ASX: CSL) share price hit a 6-month high of $212.84 today and it's not just because sell side research analysts at the likes of Goldman Sachs and Citigroup remain positive on the company.

Goldmans recently put a $223 12-month share price target on CSL shares that is probably encouraging investors to bid the stock higher given today's level is still around 5% below its target price. 

Another big factor likely supporting CSL is this week's resumption in the fall of the Australian dollar versus the U.S. dollar, with local jobs data today coming in weaker than expected in a result that has seen the Australian dollar fall towards multi-year lows against the greenback. 

This is actually good news for local CSL shareholders though as the company earns the majority of its revenues and profits in U.S. dollars, while reporting in U.S. dollars.

Therefore the lower the Australian dollar falls versus the U.S. dollar the more CSL's profits are worth to local shareholders.

Dividend payments for example are exchanged into Australian dollars for payment to local investors meaning as the Aussie dollar falls the value of the dividend payments rises inversely. 

It's also worth remembering it looks like the Australian dollar will be stuck in a sideways to down trend over the years ahead as analysts expect the Reserve Bank to keep cutting interest rates.

Of course this expectation is partly priced into currency exchange rates already, while CSL shares already trade on a big valuation as the currency outlook is no secret. 

However, for investors the local macro outlook means that buying companies with exposure away from the soft local economy and towards U.S. dollar earners probably still makes sense as a strategy. Share market investing is not rocket science and fortunately some of the best long-term growth companies in the healthcare space tick the boxes.

The likes of CSL, Cochlear Ltd (ASX: COH) and ResMed Inc. (ASX: RMD) are a lot more expensive than just 6 months and I'd strongly suggest they remain on investors' watch lists as high-quality local businesses.

Tom Richardson owns shares of Cochlear Ltd., CSL Ltd., and ResMed Inc. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Cochlear Ltd. and CSL Ltd. The Motley Fool Australia has recommended Cochlear Ltd. and ResMed Inc. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Businessman working and using Digital Tablet new business project finance investment at coffee cafe.
Broker Notes

Buy, hold, sell: Cochlear, South32, and Westpac shares

Analysts have given their verdict on these popular shares.

Read more »

Woman with a scared look has hands on her face.
Share Market News

These are the 10 most shorted ASX shares

Let's see which shares short sellers are targeting this week.

Read more »

A young man goes over his finances and investment portfolio at home.
Broker Notes

Buy, hold, sell: ANZ, Breville, and Macquarie shares

Is Morgans bullish or bearish on these shares in April? Let's find out.

Read more »

A man holding a cup of coffee puts his thumb up and smiles while at laptop.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

Man sitting in a plane seat works on his laptop.
Broker Notes

Down 34% in 2026, are Virgin Australia shares a good buy today?

A leading analyst delivers his outlook for Virgin Australia’s beaten-down shares.

Read more »

Red buy button on an Apple keyboard with a finger on it.
Broker Notes

Brokers name 3 ASX shares to buy right now

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A smiling woman holds a Facebook like sign above her head.
Broker Notes

Why these ASX shares are rated as buys in April

Let's see what makes them bullish on these names right now.

Read more »

Australian dollar notes in the pocket of a man's jeans, symbolising dividends.
Broker Notes

Are CBA shares still a good buy for passive income?

A leading analyst delivers his verdict on CBA’s passive income appeal.

Read more »